FindTrial
Sign In

Clinical trial on efficacy and safety of recombinant collagen skin repair single-use essence

Clinical trial on efficacy and safety of recombinant collagen skin repair single-use essence

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096324
Enrollment
Unknown
Registered
2025-01-21
Start date
2025-01-22
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sensitive skin

Interventions

Test group:Use recombinant collagen skin repair single-use essence

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, = 3 scors; 4. Willing to comply with the test requirements and complete the entire test for a total of 4 weeks, able to complete follow-up as required 5. Project informed consent and signing of informed consent form

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.), or obvious wounds, abrasions, tattoos, etc. in or near the testing area; 3. Participated in similar tests within 1 month; 4. Participate in other clinical trial researchers; 5. Experts or professionals believe that there are other iatrogenic reasons that may affect the test results.

Design outcomes

Primary

MeasureTime frame
redness;Loss of moisture through the epidermis;—

Secondary

MeasureTime frame
moisture content of skin stratum corneum;Current sensing threshold;Lactic acid stinging;Security assessment;—

Countries

China

Contacts

Public ContactWang Xi

West China Hospital, Sichuan University

xierwang@126.com+86 28 8542 2300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026